{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:20:56Z","timestamp":1794579656867,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Innovation and Entrepreneurship Training Program for Undergraduate","award":["202510315035"],"award-info":[{"award-number":["202510315035"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304729"],"award-info":[{"award-number":["82304729"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574587"],"award-info":[{"award-number":["82574587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230457"],"award-info":[{"award-number":["BK20230457"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Foundation of Nanjing University of Chinese Medicine","award":["ZYXYL2024-005"],"award-info":[{"award-number":["ZYXYL2024-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04532-w","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:45:13Z","timestamp":1778539513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel nasal mucosal peptide-modified co-delivery system for ginsenoside Rg1, Rb1, and notoginseng saponin R1 in the amelioration of AD"],"prefix":"10.1186","volume":"24","author":[{"given":"Yinjia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"4532_CR1","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","volume":"19","author":"L Crews","year":"2010","unstructured":"Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease. Hum Mol Genet. 2010;19:R12\u201320. https:\/\/doi.org\/10.1093\/hmg\/ddq160.","journal-title":"Hum Mol Genet"},{"key":"4532_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol. 2009;118:103\u201313. https:\/\/doi.org\/10.1007\/s00401-009-0522-3.","journal-title":"Acta Neuropathol"},{"key":"4532_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141:1917\u201333. https:\/\/doi.org\/10.1093\/brain\/awy132.","journal-title":"Brain"},{"key":"4532_CR4","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye X-Y, et al. Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev. 2022;77:101619. https:\/\/doi.org\/10.1016\/j.arr.2022.101619.","journal-title":"Ageing Res Rev"},{"key":"4532_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.proghi.2016.01.001","volume":"51","author":"AS Hung","year":"2016","unstructured":"Hung AS, Liang Y, Chow TC, et al. Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review. Prog Histochem Cytochem. 2016;51:1\u20138. https:\/\/doi.org\/10.1016\/j.proghi.2016.01.001.","journal-title":"Prog Histochem Cytochem"},{"key":"4532_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, et al. Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol. 2010;9:702\u201316. https:\/\/doi.org\/10.1016\/S1474-4422(10)70119-8.","journal-title":"Lancet Neurol"},{"key":"4532_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jgr.2023.03.001","volume":"47","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang Z, Liu J, et al. Panax Ginseng in the treatment of Alzheimer\u2019s disease and vascular dementia. J Ginseng Res. 2023;47:506\u201314. https:\/\/doi.org\/10.1016\/j.jgr.2023.03.001.","journal-title":"J Ginseng Res"},{"key":"4532_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.phymed.2014.05.004","volume":"21","author":"N Zhou","year":"2014","unstructured":"Zhou N, Tang Y, Keep RF, et al. Antioxidative effects of Panax notoginseng saponins in brain cells, Phytomedicine. Int J Phytotherapy Phytopharmacology. 2014;21:1189\u201395. https:\/\/doi.org\/10.1016\/j.phymed.2014.05.004.","journal-title":"Int J Phytotherapy Phytopharmacology"},{"key":"4532_CR9","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.18632\/aging.202619","volume":"13","author":"H-Y Liang","year":"2021","unstructured":"Liang H-Y, Zhang P-P, Zhang X-L, et al. Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer\u2019s disease. Aging. 2021;13:7549\u201369. https:\/\/doi.org\/10.18632\/aging.202619.","journal-title":"Aging"},{"key":"4532_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jep.2010.11.054","volume":"133","author":"R Zhao","year":"2011","unstructured":"Zhao R, Zhang Z, Song Y, et al. Implication of phosphatidylinositol-3 kinase\/Akt\/glycogen synthase kinase-3\u03b2 pathway in ginsenoside Rb1\u2019s attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation. J Ethnopharmacol. 2011;133:1109\u201316. https:\/\/doi.org\/10.1016\/j.jep.2010.11.054.","journal-title":"J Ethnopharmacol"},{"key":"4532_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3892\/etm.2013.1215","volume":"6","author":"Y Wang","year":"2013","unstructured":"Wang Y, Feng Y, Fu Q, et al. Panax notoginsenoside Rb1 ameliorates Alzheimer\u2019s disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression. Exp Ther Med. 2013;6:826\u201330. https:\/\/doi.org\/10.3892\/etm.2013.1215.","journal-title":"Exp Ther Med"},{"key":"4532_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fncel.2020.00280","volume":"14","author":"T Hu","year":"2020","unstructured":"Hu T, Li S, Liang W-Q, et al. Notoginsenoside R1-Induced Neuronal Repair in Models of Alzheimer Disease Is Associated With an Alteration in Neuronal Hyperexcitability, Which Is Regulated by Nav. Front Cell Neurosci. 2020;14:280. https:\/\/doi.org\/10.3389\/fncel.2020.00280.","journal-title":"Front Cell Neurosci"},{"key":"4532_CR13","doi-asserted-by":"publisher","unstructured":"Sun Y, Yang Y, Liu S, et al. New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases. Volume 11. Cells; 2022. https:\/\/doi.org\/10.3390\/cells11162529.","DOI":"10.3390\/cells11162529"},{"key":"4532_CR14","doi-asserted-by":"publisher","first-page":"914352","DOI":"10.3389\/fphar.2022.914352","volume":"13","author":"L Gong","year":"2022","unstructured":"Gong L, Yin J, Zhang Y, et al. Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases. Front Pharmacol. 2022;13:914352. https:\/\/doi.org\/10.3389\/fphar.2022.914352.","journal-title":"Front Pharmacol"},{"key":"4532_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.intimp.2014.06.018","volume":"22","author":"B Ma","year":"2014","unstructured":"Ma B, Meng X, Wang J, et al. Notoginsenoside R1 attenuates amyloid-\u03b2-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation. Int Immunopharmacol. 2014;22:151\u20139. https:\/\/doi.org\/10.1016\/j.intimp.2014.06.018.","journal-title":"Int Immunopharmacol"},{"key":"4532_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, et al. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w","journal-title":"Signal Transduct Target Ther"},{"key":"4532_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0169-409x(97)00066-5","volume":"29","author":"Y Huang","year":"1998","unstructured":"Huang Y, Donovan MD. Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Deliv Rev. 1998;29:147\u201355. https:\/\/doi.org\/10.1016\/s0169-409x(97)00066-5.","journal-title":"Adv Drug Deliv Rev"},{"key":"4532_CR18","doi-asserted-by":"publisher","unstructured":"Crowe TP, Hsu WH. Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14030629.","DOI":"10.3390\/pharmaceutics14030629"},{"key":"4532_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijpharm.2019.04.047","volume":"564","author":"J Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves J, Bicker J, Gouveia F, et al. Nose-to-brain delivery of levetiracetam after intranasal administration to mice. Int J Pharm. 2019;564:329\u201339. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.047.","journal-title":"Int J Pharm"},{"key":"4532_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1211\/jpp.59.9.0003","volume":"59","author":"VV Jogani","year":"2007","unstructured":"Jogani VV, Shah PJ, Mishra P, et al. Nose-to-brain delivery of tacrine. J Pharm Pharmacol. 2007;59:1199\u2013205. https:\/\/doi.org\/10.1211\/jpp.59.9.0003.","journal-title":"J Pharm Pharmacol"},{"key":"4532_CR21","doi-asserted-by":"publisher","unstructured":"Pires P.C., Rodrigues M, Alves G, et al. Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14030588.","DOI":"10.3390\/pharmaceutics14030588"},{"key":"4532_CR22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988;55:1189\u201393. https:\/\/doi.org\/10.1016\/0092-8674(88)90263-2.","journal-title":"Cell"},{"key":"4532_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.apsb.2016.04.001","volume":"6","author":"T Lin","year":"2016","unstructured":"Lin T, Liu E, He H, et al. Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides. Acta Pharm Sin B. 2016;6:352\u20138. https:\/\/doi.org\/10.1016\/j.apsb.2016.04.001.","journal-title":"Acta Pharm Sin B"},{"key":"4532_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jconrel.2020.01.016","volume":"319","author":"E-S Khafagy","year":"2020","unstructured":"Khafagy E-S, Kamei N, Fujiwara Y, et al. Systemic and brain delivery of leptin via intranasal coadministration with cell-penetrating peptides and its therapeutic potential for obesity. J Controlled Release: Official J Controlled Release Soc. 2020;319:397\u2013406. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.016.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"4532_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2014.11.004","volume":"197","author":"N Kamei","year":"2015","unstructured":"Kamei N, Takeda-Morishita M. Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides. J Control Release. 2015;197:105\u201310. https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.004.","journal-title":"J Control Release"},{"key":"4532_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jconrel.2021.12.034","volume":"342","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang X, Wu S, et al. Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy. J Controlled Release: Official J Controlled Release Soc. 2022;342:66\u201380. https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.034.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"4532_CR27","doi-asserted-by":"publisher","unstructured":"De Martini LB, Sulmona C, Brambilla L, et al. Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs, Cells, 12 (2023). https:\/\/doi.org\/10.3390\/cells12121643 .","DOI":"10.3390\/cells12121643"},{"key":"4532_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.msec.2016.10.063","volume":"71","author":"W Yu","year":"2017","unstructured":"Yu W, Jiang G, Liu D, et al. Fabrication of biodegradable composite microneedles based on calcium sulfate and gelatin for transdermal delivery of insulin. Mater Sci Eng C Mater Biol Appl. 2017;71:725\u201334. https:\/\/doi.org\/10.1016\/j.msec.2016.10.063.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"4532_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijpharm.2005.10.016","volume":"307","author":"AH Krauland","year":"2006","unstructured":"Krauland AH, Guggi D, Bernkop-Schn\u00fcrch A. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Int J Pharm. 2006;307:270\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.016.","journal-title":"Int J Pharm"},{"key":"4532_CR30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1021\/acsabm.8b00718","volume":"2","author":"R Chen","year":"2019","unstructured":"Chen R, Zhu C, Fan Y, et al. Polydopamine-Based Multifunctional Platform for Combined Photothermal Therapy, Chemotherapy, and Immunotherapy in Malignant Tumor Treatment. ACS Appl Bio Mater. 2019;2:874\u201383. https:\/\/doi.org\/10.1021\/acsabm.8b00718.","journal-title":"ACS Appl Bio Mater"},{"key":"4532_CR31","doi-asserted-by":"publisher","first-page":"123736","DOI":"10.1016\/j.ijbiomac.2023.123736","volume":"234","author":"Y Dong","year":"2023","unstructured":"Dong Y, He Y, Fan D, et al. Preparation of pH-sensitive chitosan-deoxycholic acid-sodium alginate nanoparticles loaded with ginsenoside Rb1 and its controlled release mechanism. Int J Biol Macromol. 2023;234:123736. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123736.","journal-title":"Int J Biol Macromol"},{"key":"4532_CR32","doi-asserted-by":"publisher","first-page":"123284","DOI":"10.1016\/j.ijpharm.2023.123284","volume":"643","author":"S Yu","year":"2023","unstructured":"Yu S, Wang X, Lv L, et al. Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression. Int J Pharm. 2023;643:123284. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123284.","journal-title":"Int J Pharm"},{"key":"4532_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ajps.2019.11.002","volume":"15","author":"C Wu","year":"2020","unstructured":"Wu C, Li B, Zhang Y, et al. Intranasal delivery of paeoniflorin nanocrystals for brain targeting. Asian J Pharm Sci. 2020;15:326\u201335. https:\/\/doi.org\/10.1016\/j.ajps.2019.11.002.","journal-title":"Asian J Pharm Sci"},{"key":"4532_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijpharm.2011.08.019","volume":"420","author":"S Wang","year":"2011","unstructured":"Wang S, Chow MS, Zuo Z. An approach for rapid development of nasal delivery of analgesics\u2013identification of relevant features, in vitro screening and in vivo verification. Int J Pharm. 2011;420:43\u201350. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.08.019.","journal-title":"Int J Pharm"},{"key":"4532_CR35","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/10717544.2021.1895909","volume":"28","author":"K Wang","year":"2021","unstructured":"Wang K, Wang L, Chen L, et al. Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer\u2019s disease. Drug Delivery. 2021;28:580\u201393. https:\/\/doi.org\/10.1080\/10717544.2021.1895909.","journal-title":"Drug Delivery"},{"key":"4532_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","volume":"270","author":"PC Pires","year":"2018","unstructured":"Pires PC, Santos AO. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies. J Controlled Release. 2018;270:89\u2013100. https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.047.","journal-title":"J Controlled Release"},{"key":"4532_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbi.2016.03.002","volume":"56","author":"LC Souza","year":"2016","unstructured":"Souza LC, Jesse CR, Antunes MS, et al. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-\u03b21\u201342 peptide in mice. Brain Behav Immun. 2016;56:363\u201377. https:\/\/doi.org\/10.1016\/j.bbi.2016.03.002.","journal-title":"Brain Behav Immun"},{"key":"4532_CR38","doi-asserted-by":"publisher","unstructured":"Yang X, Yang W, Xia X, et al. Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer\u2019s Disease Therapy, Small (Weinheim an der Bergstrasse, Germany), 18 (2022) e2203182. https:\/\/doi.org\/10.1002\/smll.202203182","DOI":"10.1002\/smll.202203182"},{"key":"4532_CR39","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.peptides.2009.05.008","volume":"30","author":"BM de Souza","year":"2009","unstructured":"de Souza BM, da Silva AVR, Resende VMF, et al. Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista. Peptides. 2009;30:1387\u201395. https:\/\/doi.org\/10.1016\/j.peptides.2009.05.008.","journal-title":"Peptides"},{"key":"4532_CR40","doi-asserted-by":"publisher","unstructured":"Howl J, Howl L, Jones S. The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14. Peptides. 2018;101. https:\/\/doi.org\/10.1016\/j.peptides.2018.01.007.","DOI":"10.1016\/j.peptides.2018.01.007"},{"key":"4532_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/s0014-5793(97)00055-0","volume":"403","author":"M Dathe","year":"1997","unstructured":"Dathe M, Wieprecht T, Nikolenko H, et al. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 1997;403:208\u201312. https:\/\/doi.org\/10.1016\/s0014-5793(97)00055-0.","journal-title":"FEBS Lett"},{"key":"4532_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.bioactmat.2020.04.003","volume":"5","author":"A Jin","year":"2020","unstructured":"Jin A, Wang Y, Lin K, . Nanoparticles modified by polydopamine: Working as drug carriers. Bioactive Mater. 2020;5:522\u201341. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.04.003.","journal-title":"Bioactive Mater"},{"issue":"2","key":"4532_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.26599\/NBE.2025.9290115","volume":"17","author":"L Peng","year":"2025","unstructured":"Peng L, Liang Y, Zhang Q, et al. Nanoparticle-based Traditional Chinese Medicine for Immunotherapy in Gastrointestinal Tumors. Nano Biomed Eng. 2025;17(2):161\u201378. https:\/\/doi.org\/10.26599\/NBE.2025.9290115.","journal-title":"Nano Biomed Eng"},{"issue":"24","key":"4532_CR44","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.3390\/polym14245486","volume":"14","author":"J Manzanares-G\u00f3mez","year":"2022","unstructured":"Manzanares-G\u00f3mez J, Le\u00f3n S, Climent-Pascual E, et al. Molecular Dynamics Simulations of Polydopamine Nanosphere\u2019s Structure Based on Experimental Evidence. Polym (Basel). 2022;14(24):5486. https:\/\/doi.org\/10.3390\/polym14245486.","journal-title":"Polym (Basel)"},{"key":"4532_CR45","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1038\/s41467-023-43070-z","volume":"14","author":"D Wu","year":"2023","unstructured":"Wu D, Zhou J, Zheng Y, et al. Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke. Nat Commun. 2023;14:7147. https:\/\/doi.org\/10.1038\/s41467-023-43070-z.","journal-title":"Nat Commun"},{"issue":"5","key":"4532_CR46","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1021\/acsami.8b18107","volume":"11","author":"B Poinard","year":"2019","unstructured":"Poinard B, Kamaluddin S, Tan AQQ, et al. Polydopamine Coating Enhances Mucopenetration and Cell Uptake of Nanoparticles. ACS Appl Mater Interfaces. 2019;11(5):4777\u201389. https:\/\/doi.org\/10.1021\/acsami.8b18107","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04532-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:35:12Z","timestamp":1783564512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04532-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4532"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04532-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments adhered to the guidelines stipulated and approved by the Animal Committee of Nanjing University of Chinese Medicine (SYXK-2023-0077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"629"}}